BullishAgent BullishAgent Filings Market Economic Earnings Ratings IPOs Insiders Institutional ETFs Funds Screener
Sign in Register

MDXH

MDxHealth S.A. NASDAQ Listed Nov 4, 2021
Healthcare ·Medical - Diagnostics & Research ·BE · mdxhealth.com
$2.02
Mkt Cap $103.8M
52w Low $1.70 8.8% of range 52w High $5.33
50d MA $2.64 200d MA $3.39
P/E (TTM) -3.1x
EV/EBITDA -39.5x
P/B
Debt/Equity -7.9x
ROE
P/FCF -15.4x
RSI (14)
ATR (14)
Beta 0.38
50d MA $2.64
200d MA $3.39
Avg Volume 157.6K
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
SIC Code
8071
CIK (SEC)
Phone
32 4 257 70 21
CAP Business Center · Herstal, C9 4040 · BE
Data updated apr 26, 2026 11:46am · Source: massive.com